Evidence map›Paper›PMID 32841053›Full record

ArticleCell transplantation

Long Noncoding RNA ZFAS1 Promotes Progression of NSCLC via Regulating of miR-590-3p.

Yumei Zhou, Lengge Si, Zihao Liu, Yanchun Shi, B Agula

Open access · goldAbstract read
In one paragraph

Article in Cell transplantation. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. TEP RNA: a new frontier for early diagnosis of NSCLC.Journal of cancer research and clinical oncology · 2024
    Review
  4. Resveratrol regulatesToxicology research · 2022
    Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Yumei ZhouInner Mongolia Key Lab of Molecular Biology, School of Basic Medical Sciences, 66287Inner Mongolia Medical University, Hohhot, China.
Lengge SiMongolian Medical College, 66287Inner Mongolia Medical University, Hohhot, China.
Zihao LiuDepartment of Cancer Prevention, 74675Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, China.
Yanchun ShiInner Mongolia Key Lab of Molecular Biology, School of Basic Medical Sciences, 66287Inner Mongolia Medical University, Hohhot, China.ORCID 0000-0001-6479-2818
B AgulaBaotou Medical College, Baotou, China.
Inner Mongolia Medical University · CNBaotou Medical College · CNTianjin Medical University Cancer Institute and Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incidence and mortality rate of nonsmall cell lung cancer (NSCLC) are continuously increasing. Recently, the important roles of long noncoding ribonucleic acid (lncRNA) zinc finger antisense1 (ZFAS1) in the development of many disease have been proved. However, the roles of ZFAS1 in NSCLC are still not completely understood. Thus, this study aimed to explore the potential roles and underlying mechanisms of lncRNA ZFAS1 in the progression of NSCLC. Our results demonstrated that lncRNA ZFAS1 expression was significantly upregulated in NSCLC tissues and cell lines. Loss-of-function experiments revealed that lncRNA ZFAS1 inhibition could remarkably suppress NSCLC cells proliferation

Indexed as

Carcinoma, Non-Small-Cell LungCell Line, TumorDisease ProgressionHumansLung NeoplasmsMicroRNAsRNA, Long NoncodingTransfectionMicroRNAsMIRN590 microRNA, humanRNA, Long NoncodingZFAS1 long non-coding RNA, humanCdc42cell proliferationmiR-590-3pNSCLCZFAS1

Identifiers

PMID32841053
PMCPMC7586268
OpenAlexW3080654058

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.